In this issue of Clinical Watch, we highlight osteoarthritis treatment options and suggest prior authorization criteria for a new multiple sclerosis therapy. Lastly, we review claims data for osteoarthritis management across several clients.
For more information about a topic, please contact Janelle Sheen, Karen Powell or Mary-Beth Plum. Be sure to watch for future monthly updates. For more information about our solutions, please visit conduent.com/pharmacysolutions.